Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma
Mh. Delfau-larue et al., Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma, BLOOD, 96(9), 2000, pp. 2987-2992
It is now widely accepted that polymerase chain reaction (PCR) analysis of
cutaneous T-cell clonality is of diagnostic value in cutaneous T-cell lymph
omas (CTCLs) and most helpful in the diagnosis of mycosis fungoides (MF), H
owever, the diagnostic and prognostic value of circulating clonal T cells r
emains unclear. We studied T-cell clonality in the peripheral blood (PB) an
d the cutaneous lesion, sampled at the same time, in 363 consecutively seen
patients with a clinical suspicion of cutaneous lymphoma. Using a PCR tech
nique providing a specific imprint of T-cell clones (PCR gamma -denaturing
gradient gel electrophoresis), we found that detection of identical circula
ting and cutaneous T-cell clones was associated with the diagnosis of CTCL
(P < .001), Detection of circulating tumor cells in patients with MF was in
frequent (12.5%), except in those with erythrodermic MF (42%; P = .003), Mo
reover, among the 46 patients who had identical circulating and cutaneous T
-cell clones, 25 (56%) had erythroderma, The finding of a dominant clone in
the PB but not in the skin was frequent, regardless of the clinicohistolog
ic classification; it occurred in 30% of patients with CTCL, 41% with non-C
TCL malignant infiltrates, and 34% with benign infiltrates. This pattern wa
s significantly more frequent in patients over 60 years of age (P < .002),
even in the CTCL group (P < .01), In conclusion, dominant T-cell clones det
ected in the PB of patients with MF by using a routine PCR technique are ra
rely tumoral and are more often related to age. A multicenter prospective s
tudy is under way to establish the prognostic value of circulating tumor ce
lls. (C) 2000 by The American Society of Hematology.